(R)-3-(Boc-Amino)piperidine CAS 309956-78-3 Linagliptin and Alogliptin Benzoate Intermediate Purity ≥99.0% Factory

Chemical Name: (R)-3-(Boc-Amino)piperidine  CAS: 309956-78-3 Chiral Purity: ≥99.0% Chemical Purity (GC): ≥99.0% Appearance: White Powder Intermediate for Linagliptin (CAS: 668270-12-0) and Alogliptin Benzoate (CAS: 850649-62-6) High Quality, Commercial Production E-Mail: alvin@ruifuchem.com

Products Details

Chemical Properties:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement. Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.Manufacturer Supply Linagliptin and Related Intermediates: Linagliptin CAS 668270-12-0 Linagliptin Parent Nucleus Intermediate CAS 853029-57-9 8-Bromo-3-Methylxanthine CAS 93703-24-3 8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4 2-(Chloromethyl)-4-Methylquinazoline CAS 109113-72-6 (R)-3-(Boc-Amino)piperidine CAS 309956-78-3 (R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4 1-Bromo-2-Butyne CAS 3355-28-0
Item Specifications
Appearance White Powder
Melting Point 120.0~125.0℃
Water (K.F) ≤0.50%
Residue on Ignition ≤0.50%
Chiral Purity ≥99.0%
Chemical Purity (GC) ≥99.0%
Total Impurities ≤1.0%
Test Standard Enterprise Standard
Usage Intermediate of Linagliptin (CAS: 668270-12-0), Alogliptin Benzoate (CAS: 850649-62-6)

Description:

Specifications:

Package & Storage:

Chemical Name (R)-3-(Boc-Amino)piperidine
Synonyms (R)-3-(tert-Butoxycarbonylamino)piperidine
CAS Number 309956-78-3
CAT Number RF-PI499
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C10H20N2O2
Molecular Weight 200.28
Solubility Soluble in Methanol and Ethanol
Brand Ruifu Chemical

Advantages:

FAQ:

Application:

(R)-3-(Boc-Amino)piperidine (CAS: 309956-78-3) has been used as a reactant for the preparation of dipeptidyl peptidase IV inhibitors derived from Alogliptin Benzoate (CAS: 850649-62-6). (R)-3-(Boc-Amino)piperidine also can be used as an intermediate of Linagliptin (CAS: 668270-12-0). Linagliptin is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes, was approved by the US FDA on 2 May 2011.

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours